Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes | |
Xiao, Yang; Liu, Lingjiao; Xu, Aimin; Zhou, Pengcheng; Long, Zhaofeng; Tu, Yiting; Chen, Xiaoyan; Tang, Weili; Huang, Gan; Zhou, Zhiguang* | |
刊名 | Cardiovascular Diabetology |
2015 | |
卷号 | 14期号:1页码:72 |
关键词 | Fibroblast growth factor 21 Intima-media thickness Subclinical atherosclerosis Type 2 diabetes |
ISSN号 | 1475-2840 |
DOI | 10.1186/s12933-015-0229-9 |
URL标识 | 查看原文 |
WOS记录号 | WOS:000356481300001 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/3320215 |
专题 | 中南大学 |
作者单位 | 1.[Liu, Lingjiao 2.Chen, Xiaoyan 3.Zhou, Zhiguang 4.Tang, Weili 5.Tu, Yiting 6.Xiao, Yang 7.Huang, Gan] Cent S Univ, Key Lab Diabet Immunol, Natl Clin Res Ctr Metab Dis, Minist Educ,Xiangya Hosp 2,Diabet Ctr, Changsha, Hunan, Peoples R China. |
推荐引用方式 GB/T 7714 | Xiao, Yang,Liu, Lingjiao,Xu, Aimin,et al. Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes[J]. Cardiovascular Diabetology,2015,14(1):72. |
APA | Xiao, Yang.,Liu, Lingjiao.,Xu, Aimin.,Zhou, Pengcheng.,Long, Zhaofeng.,...&Zhou, Zhiguang*.(2015).Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes.Cardiovascular Diabetology,14(1),72. |
MLA | Xiao, Yang,et al."Serum fibroblast growth factor 21 levels are related to subclinical atherosclerosis in patients with type 2 diabetes".Cardiovascular Diabetology 14.1(2015):72. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论